Johnson, Sarah Charlotte
Cunningham, Matthew
Dippenaar, Ilse N.
Sharara, Fablina
Wool, Eve E.
Agesa, Kareha M.
Han, Chieh
Miller-Petrie, Molly K.
Wilson, Shadrach
Fuller, John E.
Balassyano, Shelly
Bertolacci, Gregory J.
Davis Weaver, Nicole
,
Arabloo, Jalal
Badawi, Alaa
Bhagavathula, Akshaya Srikanth
Burkart, Katrin
Cámera, Luis Alberto
Carvalho, Felix
Castañeda-Orjuela, Carlos A.
Choi, Jee-Young Jasmine
Chu, Dinh-Toi
Dai, Xiaochen
Dianatinasab, Mostafa
Emmons-Bell, Sophia
Fernandes, Eduarda
Fischer, Florian
Ghashghaee, Ahmad
Golechha, Mahaveer
Hay, Simon I.
Hayat, Khezar
Henry, Nathaniel J.
Holla, Ramesh
Househ, Mowafa
Ibitoye, Segun Emmanuel
Keramati, Maryam
Khan, Ejaz Ahmad
Kim, Yun Jin
Kisa, Adnan
Komaki, Hamidreza
Koyanagi, Ai
Larson, Samantha Leigh
LeGrand, Kate E.
Liu, Xuefeng
Majeed, Azeem
Malekzadeh, Reza
Mohajer, Bahram
Mohammadian-Hafshejani, Abdollah
Mohammadpourhodki, Reza
Mohammed, Shafiu
Mohebi, Farnam
Mokdad, Ali H.
Molokhia, Mariam
Monasta, Lorenzo
Moni, Mohammad Ali
Naveed, Muhammad
Nguyen, Huong Lan Thi
Olagunju, Andrew T.
Ostroff, Samuel M.
Kan, Fatemeh Pashazadeh
Pereira, David M.
Pham, Hai Quang
Rawaf, Salman
Rawaf, David Laith
Renzaho, Andre M. N.
Ronfani, Luca
Samy, Abdallah M.
Senthilkumaran, Subramanian
Sepanlou, Sadaf G.
Shaikh, Masood Ali
Shaw, David H.
Shibuya, Kenji
Singh, Jasvinder A.
Skryabin, Valentin Yurievich
Skryabina, Anna Aleksandrovna
Spurlock, Emma Elizabeth
Tadesse, Eyayou Girma
Temsah, Mohamad-Hani
Tovani-Palone, Marcos Roberto
Tran, Bach Xuan
Tsegaye, Gebiyaw Wudie
Valdez, Pascual R.
Vishwanath, Prashant M.
Vu, Giang Thu
Waheed, Yasir
Yonemoto, Naohiro
Lozano, Rafael
Lopez, Alan D.
Murray, Christopher J. L.
Naghavi, Mohsen http://orcid.org/0000-0002-6209-1513
Funding for this research was provided by:
Bill & Melinda Gates Foundation (INV-008166)
Article History
Received: 23 December 2020
Accepted: 21 April 2021
First Online: 2 June 2021
Declarations
:
: The GBD study used de-identified data, and the waiver of informed consent was reviewed and approved by the University of Washington Institutional Review Board (application number 46665).
: Not applicable.
: Dr. Singh reports personal fees from Crealta/Horizon, Medisys, Fidia, UBM LLC, Trio health, Adept Field solutions, Medscape, WebMD, Clinical Care options, Clearview healthcare partners, Putnam associates, Focus forward, Navigant consulting, Spherix, Practice Point communications, the National Institutes of Health and the American College of Rheumatology, personal fees from Simply Speaking, ownership in stock options from Amarin, Viking, Moderna, Vaxart pharmaceuticals, and Charlotte’s Web Holdings, non-financial support from FDA Arthritis Advisory Committee, non-financial support from Steering committee of OMERACT, an international organization that develops measures for clinical trials and receives arm’s length funding from 12 pharmaceutical companies, non-financial support from Veterans Affairs Rheumatology Field Advisory Committee, non-financial support from Editor and the Director of the UAB Cochrane Musculoskeletal Group Satellite Center on Network Meta-analysis, outside the submitted work.